Clinical Trials Directory

Trials / Completed

CompletedNCT01718262

Study Measuring Total Plasma Ropivacaine Levels During Continuous Peripheral Nerve Catheter Infusion

Status
Completed
Phase
Study type
Observational
Enrollment
49 (actual)
Sponsor
Defense and Veterans Center for Integrative Pain Management · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to measure the blood levels of the medicine called ropivacaine (local anesthetic) used to manage pain. Ropivacaine is a widely used medication and is not the subject of this study, but the investigators are studying how much of the drug can be found in the patient's blood, known as the blood level, of this medicine. Too much ropivacaine in a patient's blood can lead to local anesthetic toxicity. Once the nerve catheter is removed, local anesthetic toxicity is no longer a potential problem. However, there is little data on what ropivacaine blood levels are after having the catheter in for a long period of time(up to one month).

Conditions

Timeline

Start date
2010-04-01
Primary completion
2011-11-01
Completion
2011-11-01
First posted
2012-10-31
Last updated
2019-08-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01718262. Inclusion in this directory is not an endorsement.

Study Measuring Total Plasma Ropivacaine Levels During Continuous Peripheral Nerve Catheter Infusion (NCT01718262) · Clinical Trials Directory